1 Min Read
July 3 (Reuters) - Frontier Ip Group Plc:
* Portfolio company Exscientia announced that it entered into a strategic drug discovery collaboration with Glaxosmithkline Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.